Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-15.2%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 54.63% | -36.2% |
| 2024 | 85.61% | +8.2% |
| 2023 | 79.09% | -11.7% |
| 2022 | 89.60% | +17.3% |
| 2021 | 76.39% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |